ow-dose ketamine effectiveness in acute coronary syndrome

Phase 3

Recruiting

• Conditions: Acute Coronary Syndrome.; Ischaemic heart diseases; I60-I69

• Registration Number: IRCT20190611043864N1
• Lead Sponsor: Karaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Age above 18 years old
-Age below 65 years old
-Satisfaction for participating in study
-Patients with acute coronary syndrome that has VAS more or equal to 9 and unstable haemodynamic (Systolic blood pressure less than or equal to 90 mm Hg or diastolic blood pressure less than or equal to 60 mm Hg or both)
-Lack of precedent of sensitiveness to ketamine

Exclusion Criteria

-Dissatisfaction for participating in study
-Age below than 18 years old
-Age above than 65 years old
-Weight below than 40 Kg
-Drug or alcohol intoxication
-Active psychiatric disorder
-Heart rate more than 100 per minute

Study & Design

• Study Type: interventional
• Study Design: Not specified